Literature DB >> 9638477

Thymopentin and splenopentin as immunomodulators. Current status.

V K Singh1, S Biswas, K B Mathur, W Haq, S K Garg, S S Agarwal.   

Abstract

Splenopentin (SP-5, Arg-Lys-Glu-Val-Tyr) and thymopentin (TP-5, Arg-Lys-Asp-Val-Tyr) are synthetic immunomodulating peptides corresponding to the region 32-34 of a splenic product called splenin (SP) and the thymic hormone thymopoietin (TP), respectively. TP was originally isolated as a 5-kDa (49-amino acids) protein from bovine thymus while studying effects of the thymic extracts on neuromuscular transmission and was subsequently observed to affect T cell differentiation and function. TP I and II are two closely related polypeptides isolated from bovine thymus. A radioimmunoassay for TP revealed a crossreaction with a product found in spleen and lymph node. This product, named splenin, differs from TP only in position 34, aspartic acid for bovine TP and glutamic acid for bovine splenin and it was called TP III as well. Synthetic pentapeptides (TP-5) and (SP-5), reproduce the biological activities of TP and SP, respectively. It is now evident that various forms of TPs were created by proteolytic cleavage of larger proteins during isolation. cDNA clones have been isolated for three alternatively spliced mRNAs that encodes three distinct human T cell TPs. The immunomodulatory properties of TP, SP, TP-5, SP-5 and some of their synthetic analogs reported in the literature have been briefly reviewed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9638477     DOI: 10.1007/BF02786456

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  145 in total

1.  [Role of non-protein factor of splenin in the regulation of antibody formation].

Authors:  B V Oliĭnyk; L V Bogdanovych; M H Zhuravskyĭ
Journal:  Fiziol Zh       Date:  1994 Jan-Feb

2.  Thymopoietin radioreceptor assay utilizing lectin-purified glycoprotein from a biologically responsive T cell line.

Authors:  T Audhya; M A Talle; G Goldstein
Journal:  Arch Biochem Biophys       Date:  1984-10       Impact factor: 4.013

3.  In vitro enhancement of bone marrow natural killer cells after incubation with thymopoietin32-36 (TP-5).

Authors:  M Fiorilli; M C Sirianni; V Sorrentino; R Testi; F Aiuti
Journal:  Thymus       Date:  1983-09

4.  Age-dependent changes of B-cell reactivity and T cell-T cell interaction in the in vitro antibody response.

Authors:  G Doria; G D'Agostaro; M Garavini
Journal:  Cell Immunol       Date:  1980-07-15       Impact factor: 4.868

5.  Thymopoietin in rheumatoid arthritis.

Authors:  P A Thrower; D V Doyle; J Scott; E C Huskisson
Journal:  Rheumatol Rehabil       Date:  1982-05

6.  [Therapeutic use of splenopentin (DA SP-5) in patients with psoriasis arthropathica].

Authors:  J Greiner; M Miehe; H Weber; A Stoimenov; N Sönnichsen; W Diezel
Journal:  Dermatol Monatsschr       Date:  1990

7.  The effects of thymopentin on the development of SLE-like syndrome in the MRL/lpr-lpr mouse.

Authors:  F Nicoletti; P Zaccone; G Magro; W Barcellini; V Cavallaro; G Belli; C Cocuzza; R di Marco; P L Meroni
Journal:  Scand J Immunol       Date:  1994-11       Impact factor: 3.487

8.  Thymopentin treatment in severe atopic dermatitis--clinical and immunological evaluations.

Authors:  K H Hsieh; M F Shaio; T N Liao
Journal:  Arch Dis Child       Date:  1992-09       Impact factor: 3.791

Review 9.  Atopic dermatitis: recent trends in pathogenesis and therapy.

Authors:  K D Cooper
Journal:  J Invest Dermatol       Date:  1994-01       Impact factor: 8.551

Review 10.  Thymopoietin to thymopentin: experimental studies.

Authors:  G Goldstein; T K Audhya
Journal:  Surv Immunol Res       Date:  1985
View more
  16 in total

1.  Inhalable microparticles as carriers for pulmonary delivery of thymopentin-loaded solid lipid nanoparticles.

Authors:  Yan-Zhen Li; Xun Sun; Tao Gong; Jie Liu; Jiao Zuo; Zhi-Rong Zhang
Journal:  Pharm Res       Date:  2010-07-13       Impact factor: 4.200

2.  Thymopentin-loaded phospholipid-based phase separation gel with long-lasting immunomodulatory effects: in vitro and in vivo studies.

Authors:  Ting Zhang; Xian-Yan Qin; Xi Cao; Wen-Hao Li; Tao Gong; Zhi-Rong Zhang
Journal:  Acta Pharmacol Sin       Date:  2018-07-12       Impact factor: 6.150

3.  Immuno-modulator metallo-Peptide reduces inflammatory state in obese zucker fa/fa rats.

Authors:  Antonieta Gómez-Solís; Jorge Reyes-Esparza; Francisco García-Vázquez; Elizabeth Alvarez-Ayala; Lourdes Rodríguez-Fragoso
Journal:  Int J Biomed Sci       Date:  2014-09

4.  Isolation and immunomodulatory activity of bursal peptide, a novel bursal peptide from the chicken bursa of Fabricius.

Authors:  Xiao-Dong Liu; Yingjuan Qian; Yong-Sam Jung; Pu-Yan Chen
Journal:  J Vet Sci       Date:  2015       Impact factor: 1.672

5.  A Hybrid Peptide DEFB-TP5 Expressed in Methylotrophic Yeast Neutralizes LPS With Potent Anti-inflammatory Activities.

Authors:  Baseer Ahmad; Zhongxuan Li; Quratulain Hanif; Qingyong Hu; Xubiao Wei; Lulu Zhang; Shahzad Akbar Khan; Maierhaba Aihemaiti; Huma Gulzar; Muhammad Shahid; Dayong Si; Rijun Zhang
Journal:  Front Pharmacol       Date:  2020-05-07       Impact factor: 5.810

6.  Preparation, intestinal segment stability, and mucoadhesion properties of novel thymopentin-loaded chitosan derivatives coated with poly (n-butyl) cyanoacrylate nanoparticles.

Authors:  Ying Xu; Shengzhe Lu; Qi Liu; Yun Hong; Bohui Xu; Qineng Ping; Xuefeng Jin; Yan Shen; Thomas J Webster; Yuefeng Rao
Journal:  Int J Nanomedicine       Date:  2019-03-04

7.  Design and Development of a Novel Peptide for Treating Intestinal Inflammation.

Authors:  Lulu Zhang; Xubiao Wei; Rijun Zhang; Jim N Petitte; Dayong Si; Zhongxuan Li; Junhao Cheng; Mengsi Du
Journal:  Front Immunol       Date:  2019-08-06       Impact factor: 7.561

8.  A Novel Peptide Ameliorates LPS-Induced Intestinal Inflammation and Mucosal Barrier Damage via Its Antioxidant and Antiendotoxin Effects.

Authors:  Lulu Zhang; Xubiao Wei; Rijun Zhang; Dayong Si; James N Petitte; Baseer Ahmad; Manyi Zhang
Journal:  Int J Mol Sci       Date:  2019-08-15       Impact factor: 5.923

9.  Targeting the TLR2 Receptor With a Novel Thymopentin-Derived Peptide Modulates Immune Responses.

Authors:  Xubiao Wei; Lulu Zhang; Rijun Zhang; Rujuan Wu; James N Petitte; Yanfei Hou; Dayong Si; Baseer Ahmad; Henan Guo; Manyi Zhang; Qiang Cheng; Yucui Tong
Journal:  Front Immunol       Date:  2021-05-27       Impact factor: 7.561

10.  Molecular analysis of thymopentin binding to HLA-DR molecules.

Authors:  Zuojia Liu; Xiliang Zheng; Jin Wang; Erkang Wang
Journal:  PLoS One       Date:  2007-12-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.